JANUMET XR 500 mg/1

JANUMET XR 500 mg/1 is a combination of sitagliptin and metformin hydrochloride, designed for extended-release oral administration. This medication is commonly used to manage type 2 diabetes by improving blood sugar control. It is manufactured by Merck Sharp & Dohme LLC in the USA.

JANUMET XR 500 mg/1 is primarily used to help manage type 2 diabetes in adults. It works by combining two active ingredients, sitagliptin and metformin hydrochloride, to improve blood sugar levels. This medication is often prescribed for individuals who require additional glycemic control beyond diet and exercise alone. It is important to consult a healthcare provider to determine if this medication is suitable for your specific needs.

Common effects of JANUMET XR 500 mg/1 may include gastrointestinal discomfort, such as nausea, diarrhea, or abdominal pain. Some individuals may also experience headache or dizziness. These effects can vary from person to person and may subside as the body adjusts to the medication. Always consult a healthcare provider if you experience persistent or severe side effects.

JANUMET XR 500 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication should be stored at room temperature, away from moisture and heat. Do not crush or chew the extended-release tablets, as this can affect their effectiveness. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

JANUMET XR 500 mg/1 may interact with certain medications, including other diabetes drugs, antibiotics, and medications that affect kidney function. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all the medications you are taking to ensure safe and effective use of JANUMET XR 500 mg/1.